Morgan Lewis Advised LTS Lothmann Therapie-Systeme AG On Acquisition Of Renaissance Lakewood

Morgan Lewis Advised LTS Lothmann Therapie-Systeme AG on Acquisition of Renaissance Lakewood

Morgan Lewis advised LTS Lohmann Therapie-Systeme AG, a pharmaceutical technology company, in its acquisition of Renaissance Lakewood, a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms. First announced in October 2025, the transaction has now completed following regulatory approvals.

The acquisition broadens LTS’s capabilities in the CDMO sector, with Renaissance’s facilities and teams joining existing LTS sites in Germany, the United States, and Israel.

The Morgan Lewis team led by LTS includes Sheryl Orr (Partner), and Alexandre Martin (Associate), along with Torsten Schwarze (Partner), Jon English (Partner), Ulrich Korth (Partner), and Christian Zschocke (Partner), and Nardos Bekele (Associate), Michelle Lippenmeyer (Associate), and Emily Pollak (Associate).

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.